Cargando…

Immunophenotype of Measurable Residual Blast Cells as an Additional Prognostic Factor in Adults with B-Cell Acute Lymphoblastic Leukemia

Measurable residual disease (MRD) is a well-known independent prognostic factor in acute leukemias, and multicolor flow cytometry (MFC) is widely used to detect MRD. MFC is able not only to enumerate MRD accurately but also to describe an antigen expression profile of residual blast cells. However,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davydova, Yulia, Galtseva, Irina, Kapranov, Nikolay, Nikiforova, Ksenia, Aleshina, Olga, Chabaeva, Yulia, Isinova, Galina, Kotova, Ekaterina, Sokolov, Andrey, Troitskaya, Vera, Kulikov, Sergey, Parovichnikova, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818326/ https://www.ncbi.nlm.nih.gov/pubmed/36611312 http://dx.doi.org/10.3390/diagnostics13010021

Ejemplares similares

P396: FIFTEEN YEARS OF RUSSIAN RESEARCH IN THE TREATMENT OF ADULT PATIENTS WITH ACUTE PH-NEGATIVE LYMPHOBLASTIC LEUKEMIA ACCORDING TO THE PROTOCOLS ALL-2009 AND ALL-2016.
por: Aleshina (Gavrilina), Olga, et al.
Publicado: (2023)

PB1730: PROGNOSTIC VALUE OF EARLY T-ALL IMMUNOPHENOTYPES IN ADULTS ON THE RALL-2016 PROTOCOL
por: Vasileva, Anastasia, et al.
Publicado: (2023)

P655: LIMITATIONS OF USING CD26+ LEUKEMIA STEM CELL QUANTITATION IN CML PATIENTS TO ASSESS RESIDUAL LEUKEMIA CLONE
por: Kapranov, Nikolay, et al.
Publicado: (2023)

Immunophenotypic characteristics of multipotent mesenchymal stromal cells that affect the efficacy of their use in the prevention of acute graft vs host disease
por: Petinati, Nataliya, et al.
Publicado: (2020)

P569: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IMPROVES OVERALL AND RELAPSE-FREE SURVIVAL IN PREGNANT WOMEN WITH ACUTE MYELOID LEUKEMIA
por: Troitskaya, Vera, et al.
Publicado: (2023)

Loss of Heterozygosity in the Tumor DNA of De Novo Diagnosed Patients Is Associated with Poor Outcome for B-ALL but Not for T-ALL
por: Risinskaya, Natalya, et al.
Publicado: (2022)

Immunophenotypic changes of leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia who have been treated with blinatumomab
por: Mikhailova, Ekaterina, et al.
Publicado: (2020)

Immunophenotypic changes in leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia after treatment with CD19-directed chimeric antigen receptor (CAR)- expressing T cells
por: Mikhailova, Ekaterina, et al.
Publicado: (2021)

PB1916: SOMATIC MUTATIONS ASSOCIATED WITH MYELODYSPLASTIC SYNDROME IN RUSSIAN PATIENTS
por: Kohno, A., et al.
Publicado: (2022)

P566: RESULTS OF NON-CHEMOTERAPEUTIC TREATMENT OF PATIENTS WITH DE NOVO ACUTE PROMYELOCYTIC LEUKEMIA
por: Troitskaya, Vera, et al.
Publicado: (2023)

P1348: COMPARISON OF NATURAL KILLER CELL RECONSTITUTION AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION DEPENDING ON THE VARIANT OF T-CELL DEPLETION
por: Konova, Z., et al.
Publicado: (2022)

Immunophenotypic evolution of blast populations in pediatric acute myeloid leukemia
por: Pereira, Welbert Oliveira, et al.
Publicado: (2016)

Comparative Analysis of the Hematopoietic Progenitor Cells from Placenta, Cord Blood, and Fetal Liver, Based on Their Immunophenotype
por: Kuchma, Maria D., et al.
Publicado: (2015)

PB1866: IS ALLO-HSCT IN CR1 NECESSARY FOR AML PATIENTS WITH MRD NEGATIVITY ACHIEVED AFTER THE FIRST INDUCTION COURSE? RUSSIAN PROSPECTIVE MULTICENTER RANDOMIZED TRIAL IN AML PATIENTS UNDER THE AGE OF 60
por: Parovichnikova, Elena, et al.
Publicado: (2023)

Prognostic impact of immunophenotypic aberrancies of blasts in lower risk myelodysplastic syndrome
por: Corrao, Kristen, et al.
Publicado: (2022)

Altered neutrophil immunophenotypes in childhood B-cell precursor acute lymphoblastic leukemia
por: Oliveira, Elen, et al.
Publicado: (2016)

The Profile of Immunophenotype and Genotype Aberrations in Subsets of Pediatric T-Cell Acute Lymphoblastic Leukemia
por: Noronha, Elda Pereira, et al.
Publicado: (2019)

Gamma-Delta T-Cell Acute Lymphoblastic Leukemia/Lymphoma: Immunophenotype of Three Adult Cases
por: Wang, Wei, et al.
Publicado: (2019)

Corrigendum: The Profile of Immunophenotype and Genotype Aberrations in Subsets of Pediatric T-Cell Acute Lymphoblastic Leukemia
por: Noronha, Elda Pereira, et al.
Publicado: (2021)

Hemophagocytosis by blasts in acute lymphoblastic leukemia
por: Klein, Emilie, et al.
Publicado: (2019)

Space-time clustering analyses of childhood acute lymphoblastic leukaemia by immunophenotype
por: McNally, R J Q, et al.
Publicado: (2002)

Multicolor flow cytometry immunophenotyping and characterization of aneuploidy in pediatric B-cell precursor acute lymphoblastic leukemia
por: Pierzyna-Świtała, Magdalena, et al.
Publicado: (2021)

TCF3-HLF-Positive Acute Lymphoblastic Leukemia Resembling Burkitt Leukemia: Cell Morphologic and Immunophenotypic Findings
por: Li, Meng-Ju, et al.
Publicado: (2022)

Acute Lymphoblastic Leukemia Transformation with a Precursor B-Cell Immunophenotype to Burkitt’s Lymphoma: a Case Report
por: Jafari, Masoumeh, et al.
Publicado: (2023)

Unusual T-Lymphoblastic Blast Phase of Chronic Myelogenous Leukemia
por: Xu, Jie, et al.
Publicado: (2014)

Accumulation of STR-Loci Aberrations in Subclones of Jurkat Cell Line as a Model of Tumor Clonal Evolution
por: Risinskaya, Natalya, et al.
Publicado: (2023)

NPM1 and DNMT3A mutations are associated with distinct blast immunophenotype in acute myeloid leukemia
por: Kuželová, Kateřina, et al.
Publicado: (2022)

PB1753: EVALUATION OF IMMUNOPHENOTYPIC CHARACTERISTICS OF RESIDUAL CELLS IN COMPARISON WITH NORMAL HEMATOGONES AND MATURE CELLS IN CHILDREN WITH B-CELL LYMPHOBLASTIC LEUKEMIA
por: Karnabeda, Oksana, et al.
Publicado: (2023)

Blast phase of chronic myeloid leukemia presenting as early T‐cell precursor lymphoblastic leukemia
por: Qiu, Lianqun, et al.
Publicado: (2021)

Advanced Flow Cytometry Analysis Algorithms for Optimizing the Detection of “Different From Normal” Immunophenotypes in Acute Myeloid Blasts
por: Aanei, Carmen-Mariana, et al.
Publicado: (2021)

Role of Genetic Thrombophilia Markers in Thrombosis Events in Elderly Patients with COVID-19
por: Fevraleva, Irina, et al.
Publicado: (2023)

Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy
por: Mikhailova, Ekaterina, et al.
Publicado: (2022)

Prognostic relevance of pretreatment proliferative rapidity of marrow blast cells in childhood acute lymphoblastic leukaemia.
por: Trerè, D., et al.
Publicado: (1994)

Immunophenotype
por: Albani, Salvatore
Publicado: (2014)

Immunophenotypic markers in adult acute lymphoblastic leukemia: the prognostic significance of CD20 and TdT expression
por: Kim, Dae-Young, et al.
Publicado: (2015)

Characterization of Immunophenotypic Aberrancies in Adult and Childhood Acute Lymphoblastic Leukemia: Lessons from Regional Variation
por: Rezaei, Mitra Sadat, et al.
Publicado: (2020)

Acute Myeloid Leukemia Causes Serious and Partially Irreversible Changes in Secretomes of Bone Marrow Multipotent Mesenchymal Stromal Cells
por: Sadovskaya, Aleksandra, et al.
Publicado: (2023)

Burkitt-Type Acute Lymphoblastic Leukemia With Precursor B-Cell Immunophenotype and Partial Tetrasomy of 1q: A Case Report
por: Sato, Yuya, et al.
Publicado: (2016)

Immunophenotypic measurable residual disease monitoring in adult acute lymphoblastic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation
por: Tecchio, Cristina, et al.
Publicado: (2023)

Acquisition of the Immunophenotype by Human Adrenal Cells
por: Silani, Vincenzo, et al.
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_qkg0m1m41bae8td25dq7hnja3g